JavaScript is currently not supported/disabled by this browser. Please enable JavaScript for full functionality.

Call Us 1 - 866 - 986 - 9598
[email protected]

Sign Up

Login
- My Order
- Return Requests
- Track my Order

Home / Proteins & Peptide

CREBBP (KAT3A), His-tag

SKU : BHP18200092

Contact us to order

Tel

+1 866.986.9598

Email

[email protected]

Get a Quote

Request More Infos

BPS Bioscience

view supplier details

Order Now

Credit card payments now incur a 3% fee.

Contact us to order

Tel

+1 866.986.9598

Email

[email protected]

Get a Quote

Ask Merchant

Request More Infos

Sample Request

Mfr.No.	31119
Description	Human bromodomain CREB binding protein (CREBBP), also known as CBP, RSTS and KAT3A, GenBank Accession No. NM_004380, a.a. 1081- 1197 corresponding to single bromodomain, with N-terminal His-tag, MW=14.9 kDa, expressed in an E. coli expression system.
Immunogen Region	1081-1197
Tag	N-terminal His-tag
Formulation	45 mM Tris-HCl, pH 8.0, 124 mM NaCl, 2.4 mM KCl, and 10% glycerol
Species	Human
Application	Useful for the study of bromodomain binding assays, screening inhibitors, and selectivity profiling.
Notes	Avoid freeze/thaw cycles.
GenBank	NM_004380
Mw(kda)	14.9 kDa

Synonyms	CREBBP, CREB bindingprotein, CBP, RSTS and KAT3A
Uniprot	Q92793

Shipping Temperature	-80°C (dry ice)
Format	Aqueous buffer solution
Storage	At least 6 months at -80°C.

Reference	1. Panagopoulos, I., et al., Hum Mol Genet. 2001 Feb 15;10(4): 395-404. 2. Huang, W.C., et al., Mol Cell. 2007 Apr 13; 26(1):75-87.

Product Manual	Datasheet

Have you used this product?

Rate it now..!!

Login to Review

SKU	Supplier No.	Size	Your price	Quantity
BHP18200092	31119	100 ug	$335.50		Add to Cart

ebiohippo.com provides biomedical researchers with a one-stop informatic shopping experience by transforming biotechnology products’ data into a ready-to-analyze state. We collect and unify suppliers’ data on a single platform to reduce the time of searching, uncertainty, and cost of scientific experiments.

© 2024 Biohippo. All rights reserved.